SEC 13F Intelligence

Managers / Q1 2026

Forefront Analytics, LLC

CIK 0001696802 · ONE TOWER BRIDGE, 100 FRONT STREET, SUITE 1111, WEST CONSHOHOCKEN, PA, 19428 · 6103413900

Reported Value
$110M
Q1 2026
Positions
39
Filings on Record
31
2019–present window
Filed
May 13, 2026
original filing

Summary

Forefront Analytics, LLC reported $110M in U.S.-listed holdings across 39 positions for Q1 2026.

The portfolio is heavily concentrated: ESGD alone accounts for 22.1% of reported value.

Compared with Q4 2025, the fund opened 4 new positions and exited 8.

Portfolio Metrics

Turnover
+13.2%
vs prior filed quarter
Top-10 Concentration
+87.2%
share of reported value
Largest Position
+22.1%
Ishares Tr
New / Exited
4 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $181MQ4 ’18Q1 ’19: $157MQ2 ’19: $235MQ3 ’19: $243MQ4 ’19: $257MQ4 ’19Q3 ’20: $214MQ4 ’20: $230MQ1 ’21: $235MQ2 ’21: $252MQ2 ’21Q3 ’21: $274MQ4 ’21: $299MQ1 ’22: $269MQ2 ’22: $206MQ2 ’22Q3 ’22: $188MQ4 ’22: $188MQ1 ’23: $194MQ2 ’23: $175MQ2 ’23Q3 ’23: $176MQ4 ’23: $203MQ1 ’24: $206MQ2 ’24: $209MQ2 ’24Q3 ’24: $212MQ4 ’24: $215MQ1 ’25: $87MQ2 ’25: $90MQ2 ’25Q3 ’25: $104MQ4 ’25: $113MQ1 ’26: $110Mfilingsflow.com

Portfolio Composition

By security type
ETP: 91.2%Common Stock: 7.9%Other: 0.5%ADR: 0.4%
  • ETP · 91.2% · $100M
  • Common Stock · 7.9% · $9M
  • Other · 0.5% · $549,555
  • ADR · 0.4% · $392,226

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SCHWAB STRATEGIC TRNEW+15.1K15.1K+$463,851$463,851
OTFBLUE OWL TECHNOLOGY FIN CORPNEW+29.7K29.7K+$367,413$367,413
LEGNLEGEND BIOTECH CORPNEW+15.7K15.7K+$283,271$283,271
DFSVDIMENSIONAL ETF TRUSTNEW+6.3K6.3K+$222,189$222,189
MREOMEREO BIOPHARMA GROUP PLCADDED+96.0K127.8K+$28,929$42,167
AOKISHARES TRSOLD OUT−58.7K0−$2M$0
FIRST TR EXCHANGE-TRADED FDSOLD OUT−18.4K0−$698,000$0
ISHARES TRSOLD OUT−4.7K0−$566,000$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

34 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ESGDISHARES TRESG AW MSCI EAFE · CORE HIGH DV ETF · MSCI USA MMENTM · CORE S&P500 ETF38.48%$42M351.2K
2ESGEISHARES INCESG AWR MSCI EM · CUR HD MSCI EM17.24%$19M428.0K
3VANGUARD INTL EQUITY INDEX FFTSE EMR MKT ETF8.86%$10M180.2K
4NUSHARES ETF TRNUVEEN ESG LRGVL8.10%$9M195.7K
5ESGGFLEXSHARES TRhistory →STOX GBL ESG SLT8.04%$9M44.2K
6DBX ETF TRXTRACK MSCI EAFE5.70%$6M126.9K
7VANGUARD TAX-MANAGED FDSVAN FTSE DEV MKT2.76%$3M47.3K
8NVDANVIDIA CORPORATIONhistory →COM2.26%$2M14.2K
9JPMJPMORGAN CHASE & COhistory →COM1.33%$1M5.0K
10PROSHARES TRPSHS ULT S&P 500 · PSHS ULTRUSS20000.72%$796,46416.2K
11DEDEERE & COCOM0.58%$640,1591.1K
12UNHUNITEDHEALTH GROUP INCCOM0.49%$536,5592.0K
13EWEDWARDS LIFESCIENCES CORPCOM0.48%$526,4466.6K
14ABTABBOTT LABORATORIESCOM0.47%$517,7265.0K
15WISDOMTREE TRUS SMALLCAP FUND0.43%$477,8818.2K
16SCHWAB STRATEGIC TRUS DIVIDEND EQ0.42%$463,85115.1K
17MEDTRONIC PLCSHS0.42%$460,8945.3K
18INCYINCYTE CORPCOM0.36%$398,4104.2K
19PFEPFIZER INCCOM0.33%$367,57813.1K
20OTFBLUE OWL TECHNOLOGY FIN CORPCOMMON STOCK0.33%$367,41329.7K
21REGNREGENERON PHARMACEUTICALSCOM0.32%$355,029460
22TMOTHERMO FISHER SCIENTIFIC INCCOM0.26%$284,553579
23LEGNLEGEND BIOTECH CORPSPONSORED ADS0.26%$283,27115.7K
24VTVVANGUARD INDEX FDSVALUE ETF0.24%$258,4731.3K
25DHRDANAHER CORP DELCOM0.22%$244,1681.3K
264I1PHILIP MORRIS INTL INCCOM0.22%$239,6641.4K
27DFSVDIMENSIONAL ETF TRUSTUS SMALL CAP VAL0.20%$222,1896.3K
28NKTXNKARTA INCCOM0.08%$92,49243.8K
29ZURA BIO LTDCLASS A ORD SHS0.08%$88,66114.9K
30GONGERON CORPCOM0.07%$82,13655.1K
31ANNXANNEXON INCCOM0.07%$78,89014.2K
32BCYCBICYCLE THERAPEUTICS PLCSPONSORED ADS0.06%$66,78814.4K
33CTMXCYTOMX THERAPEUTICS INC.COM0.05%$58,63712.5K
34MREOMEREO BIOPHARMA GROUP PLCSPON ADS0.04%$42,167127.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$110M39May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$113M47Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$104M46Nov 21, 202513F-HRchanges · EDGAR ↗
Q2 2025$90M47Aug 14, 2025RESTATEMENTchanges · EDGAR ↗
Q1 2025$87M72May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$215M113Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$212M114Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$209M114Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$206M113May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$203M112Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$176M67Nov 8, 202313F-HRchanges · EDGAR ↗
Q2 2023$175M115Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$194M138May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$188M130Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$188M115Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$206M114Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$269M119May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$299M109Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$274M118Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$252M113Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$235M114May 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$230M109Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$214M98Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020Under review92Aug 10, 202013F-HRchanges · EDGAR ↗
Q1 2020Under review179May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$257M77Feb 5, 202013F-HRchanges · EDGAR ↗
Q3 2019$243M76Nov 5, 201913F-HRchanges · EDGAR ↗
Q2 2019$235M69Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$157M69May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$181M73Feb 12, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • GKFO LLC

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.